Hunan Jiudian Pharmaceutical Co., Ltd. (300705.SZ)
CNY 23.61
(-0.38%)
CNY 23.61
(-0.38%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 2.69 Billion | 2.32 Billion | 1.62 Billion | 978.15 Million | 924.06 Million | 801.37 Million |
| Cost of Revenue | 621.78 Million | 516.98 Million | 349.9 Million | 246.02 Million | 300.54 Million | 323.67 Million |
| Gross Profit | 2.07 Billion | 1.8 Billion | 1.27 Billion | 732.13 Million | 623.51 Million | 477.69 Million |
| Operating Expenses | 1.68 Billion | 1.48 Billion | 1.02 Billion | 624.98 Million | 551.65 Million | 396.71 Million |
| Selling, General and Administrative Expenses | 1.4 Billion | 1.23 Billion | 845.49 Million | 518.92 Million | 419.52 Million | 314.91 Million |
| Research and Development Expenses | 281.45 Million | 201.26 Million | 146.26 Million | 81.67 Million | 109.8 Million | 57.49 Million |
| Other Expenses | -6.57 Million | -1.08 Million | 358.58 Thousand | -878.87 Thousand | -3.99 Million | -842.71 Thousand |
| Cost and Expenses | 2.29 Billion | 2 Billion | 1.37 Billion | 871.01 Million | 852.2 Million | 720.39 Million |
| Operating Income | 394.37 Million | 291.3 Million | 225.83 Million | 91.71 Million | 62.89 Million | 80.24 Million |
| Interest Expense | 11.06 Million | 18.42 Million | 16 Million | 5.24 Million | 4.67 Million | 1.29 Million |
| Income Tax Expense | 33.9 Million | 20.52 Million | 21.94 Million | 8.58 Million | 3.83 Million | 7.42 Million |
| Earnings before Tax | 402.16 Million | 290.22 Million | 226.19 Million | 90.84 Million | 58.89 Million | 79.4 Million |
| Net Income | 368.26 Million | 269.7 Million | 204.24 Million | 82.25 Million | 55.06 Million | 71.98 Million |
| Earnings Per Share Basic | 0.76 | 1.97 | 0.62 | 0.25 | 0.17 | 0.22 |
| Earnings Per Share Diluted | 0.76 | 1.97 | 0.62 | 0.25 | 0.17 | 0.22 |
| Weighted Average Shares Outstanding | 481.83 Million | 137.17 Million | 328.56 Million | 328.55 Million | 328.55 Million | 325.09 Million |
| Weighted Average Shares Outstanding (Diluted) | 481.83 Million | 137.17 Million | 328.56 Million | 328.55 Million | 328.55 Million | 325.09 Million |
| Gross Margin | 0.77 | 0.78 | 0.79 | 0.75 | 0.67 | 0.60 |
| EBIT Margin | 0.18 | 0.17 | 0.19 | 0.16 | 0.11 | 0.13 |
| Profit Margin | 0.14 | 0.12 | 0.13 | 0.08 | 0.06 | 0.09 |
| EBITDA | 485.76 Million | 369.21 Million | 296.76 Million | 145.25 Million | 101.49 Million | 103.44 Million |
| Earnings Before Tax Margin | 0.15 | 0.13 | 0.14 | 0.09 | 0.07 | 0.10 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 779.69 Million | 766.42 Million | 584.04 Million | 790.03 Million | 2.65 Billion | 675.21 Million |
| Cost of Revenue | 196.12 Million | 212.7 Million | 161.66 Million | 206.55 Million | 644.44 Million | 145.52 Million |
| Gross Profit | 583.57 Million | 553.72 Million | 422.37 Million | 583.47 Million | 2.01 Billion | 529.69 Million |
| Operating Expenses | 388.06 Million | 392.89 Million | 296.5 Million | 555.33 Million | 1.64 Billion | 384.25 Million |
| Selling, General and Administrative Expenses | 400.78 Million | 323.75 Million | 253.03 Million | 458.58 Million | - | 338.71 Million |
| Research and Development Expenses | 53.42 Million | 68.88 Million | 40.92 Million | 92.34 Million | - | 66.34 Million |
| Other Expenses | -66.14 Million | -250.52 Thousand | -2.54 Million | -4.4 Million | -6.57 Million | -515.51 Thousand |
| Cost and Expenses | 584.18 Million | 605.59 Million | 458.17 Million | 761.89 Million | 2.28 Billion | 529.77 Million |
| Operating Income | 189.61 Million | 160.82 Million | 125.87 Million | 28.13 Million | 369.16 Million | 142.62 Million |
| Interest Expense | 5.1 Million | 5.18 Million | 5.22 Million | 5.91 Million | 11.06 Million | 2.99 Million |
| Income Tax Expense | 23.49 Million | 12.56 Million | 19.96 Million | -20.57 Million | 33.9 Million | 29.74 Million |
| Earnings before Tax | 189.1 Million | 171.02 Million | 145.63 Million | 37.69 Million | 402.16 Million | 142.11 Million |
| Net Income | 165.6 Million | 158.46 Million | 125.66 Million | 58.27 Million | 368.26 Million | 112.36 Million |
| Earnings Per Share Basic | 0.34 | 0.33 | 0.36 | 0.17 | - | 0.33 |
| Earnings Per Share Diluted | 0.34 | 0.33 | 0.36 | 0.17 | - | 0.33 |
| Weighted Average Shares Outstanding | 487.07 Million | 486.52 Million | 345.14 Million | 345.14 Million | 344.16 Million | 345.14 Million |
| Weighted Average Shares Outstanding (Diluted) | 487.07 Million | 486.52 Million | 345.14 Million | 345.14 Million | 344.16 Million | 345.14 Million |
| Gross Margin | 0.75 | 0.72 | 0.72 | 0.74 | 0.76 | 0.78 |
| EBIT Margin | 0.25 | 0.24 | 0.25 | 0.06 | - | 0.22 |
| Profit Margin | 0.21 | 0.21 | 0.22 | 0.07 | 0.14 | 0.17 |
| EBITDA | 194.21 Million | 183.33 Million | 147.41 Million | 47.88 Million | - | 146.38 Million |
| Earnings Before Tax Margin | 0.24 | 0.21 | 0.22 | 0.04 | 0.14 | 0.21 |
IGC
STU
DHAMPURSUG
PEXZF
GSP
ORIENTELEC